[PHARMA] YoY TTM Result on 30-Sep-2019 [#3]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
20-Nov-2019
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2019
Quarter
30-Sep-2019 [#3]
Profit Trend
QoQ- -30.11%
YoY- -43.39%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
TTM Result
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
Revenue 3,359,675 4,737,880 2,806,171 2,701,491 2,401,508 2,293,580 2,286,356 6.62%
PBT 182,637 138,481 -189,175 58,549 78,146 57,267 91,665 12.16%
Tax -58,325 -58,488 43,758 -24,693 -17,398 -25,268 -28,865 12.43%
NP 124,312 79,993 -145,417 33,856 60,748 31,999 62,800 12.04%
-
NP to SH 122,548 80,344 -144,778 33,816 59,731 31,187 62,497 11.87%
-
Tax Rate 31.93% 42.24% - 42.17% 22.26% 44.12% 31.49% -
Total Cost 3,235,363 4,657,887 2,951,588 2,667,635 2,340,760 2,261,581 2,223,556 6.44%
-
Net Worth 411,327 391,428 345,040 516,387 522,618 531,892 531,250 -4.17%
Dividend
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
Div 90,356 58,895 26,125 27,347 51,957 41,490 51,803 9.71%
Div Payout % 73.73% 73.30% 0.00% 80.87% 86.99% 133.04% 82.89% -
Equity
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
Net Worth 411,327 391,428 345,040 516,387 522,618 531,892 531,250 -4.17%
NOSH 1,309,126 1,309,126 261,705 261,229 260,505 259,821 259,146 30.97%
Ratio Analysis
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
NP Margin 3.70% 1.69% -5.18% 1.25% 2.53% 1.40% 2.75% -
ROE 29.79% 20.53% -41.96% 6.55% 11.43% 5.86% 11.76% -
Per Share
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
RPS 256.47 361.91 1,073.54 1,035.84 923.62 883.98 882.26 -18.60%
EPS 9.36 6.14 -55.39 12.97 22.97 12.02 24.12 -14.58%
DPS 6.90 4.50 10.00 10.50 20.00 16.00 20.00 -16.24%
NAPS 0.314 0.299 1.32 1.98 2.01 2.05 2.05 -26.84%
Adjusted Per Share Value based on latest NOSH - 261,229
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
RPS 233.11 328.74 194.71 187.44 166.63 159.14 158.64 6.62%
EPS 8.50 5.57 -10.05 2.35 4.14 2.16 4.34 11.84%
DPS 6.27 4.09 1.81 1.90 3.61 2.88 3.59 9.73%
NAPS 0.2854 0.2716 0.2394 0.3583 0.3626 0.3691 0.3686 -4.17%
Price Multiplier on Financial Quarter End Date
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
Date 30/09/22 30/09/21 30/09/20 30/09/19 28/09/18 29/09/17 30/09/16 -
Price 0.515 0.835 4.32 2.44 2.89 4.14 5.58 -
P/RPS 0.20 0.23 0.40 0.24 0.31 0.47 0.63 -17.39%
P/EPS 5.51 13.61 -7.80 18.82 12.58 34.44 23.14 -21.26%
EY 18.17 7.35 -12.82 5.31 7.95 2.90 4.32 27.03%
DY 13.40 5.39 2.31 4.30 6.92 3.86 3.58 24.59%
P/NAPS 1.64 2.79 3.27 1.23 1.44 2.02 2.72 -8.08%
Price Multiplier on Announcement Date
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
Date 24/11/22 19/11/21 19/11/20 20/11/19 19/11/18 15/11/17 21/11/16 -
Price 0.55 0.845 5.72 2.21 3.09 3.82 5.70 -
P/RPS 0.21 0.23 0.53 0.21 0.33 0.43 0.65 -17.15%
P/EPS 5.88 13.77 -10.33 17.04 13.45 31.78 23.64 -20.68%
EY 17.01 7.26 -9.68 5.87 7.43 3.15 4.23 26.09%
DY 12.55 5.32 1.75 4.75 6.47 4.19 3.51 23.64%
P/NAPS 1.75 2.83 4.33 1.12 1.54 1.86 2.78 -7.42%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment